Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0212960B2 - - Google Patents
[go: Go Back, main page]

JPH0212960B2 - - Google Patents

Info

Publication number
JPH0212960B2
JPH0212960B2 JP17647786A JP17647786A JPH0212960B2 JP H0212960 B2 JPH0212960 B2 JP H0212960B2 JP 17647786 A JP17647786 A JP 17647786A JP 17647786 A JP17647786 A JP 17647786A JP H0212960 B2 JPH0212960 B2 JP H0212960B2
Authority
JP
Japan
Prior art keywords
temperature
saturated solution
ginsenoside
water
column chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP17647786A
Other languages
Japanese (ja)
Other versions
JPS6333393A (en
Inventor
Juji Kawashima
Keiichi Sagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NITSUKAN KORAI NINJIN KK
Original Assignee
NITSUKAN KORAI NINJIN KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NITSUKAN KORAI NINJIN KK filed Critical NITSUKAN KORAI NINJIN KK
Priority to JP17647786A priority Critical patent/JPS6333393A/en
Publication of JPS6333393A publication Critical patent/JPS6333393A/en
Publication of JPH0212960B2 publication Critical patent/JPH0212960B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) この発明は、ジンセノサイド―Rg1の精製法に
関するものである。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for purifying ginsenoside-Rg 1 .

(ジンセノサイド―Rg1) ジンセノサイド―Rg1は、下式で示される化合
物であり、オタネニンジン(Panax ginseng C.
A.Mey)の根に含まれている。
(Ginsenoside-Rg 1 ) Ginsenoside-Rg 1 is a compound represented by the following formula, and is derived from Panax ginseng (Panax ginseng C.
A.Mey) is contained in the roots.

人蔘は、中国医学の重要な薬物として古くから
知られ、日本薬局方においても修治法の違いによ
り、「ニンジン」又は「コウジン」として収載さ
れている。人蔘の成分のうち、サポニンとして
は、ジンセノサイド―Rg1など捨数種のものが知
られている。これらは混合された状態として含ま
れている。従つて、これらの混合物からジンセノ
サイド―Rg1だけを分離することは容易でない。
Ginseng has long been known as an important drug in Chinese medicine, and is listed in the Japanese Pharmacopoeia as either ``ginseng'' or ``red ginseng'' depending on the treatment method. Among the components of ginseng, several types of saponins, such as ginsenoside-Rg 1 , are known. These are included as a mixture. Therefore, it is not easy to separate only ginsenoside-Rg 1 from these mixtures.

ところで、ジンセノサイド―Rg1は、はじめ中
枢賦活作用を有することが知られていたが、近年
血小板凝集抑制作用を有することが明らかにさ
れ、動脈硬化を防止するに有効であるとされるに
至つた(中西幸三他、1982、臨床と研究 59,
3671―3674)。さらに最近では、ジンセノサイド
―Rg1は、高脂血症動物の血中脂質を改善する作
用を持つことも明らかにされるに至つた(山本昌
弘他、和漢医薬学会誌2,377〜385)。また、ジ
ンセノサイド―Rg1は、第11改正日本薬局方の
「コウジン」及び「ニンジン」において、確認試
験の薄層クロマトグラフ用標準試薬として用いら
れるに至つている。かくして、ジンセノサイド―
Rg1は、化合物として重要なものとなり、従つて
これを精製するに適当な方法を案出する必要が生
じた。
By the way, ginsenoside-Rg 1 was originally known to have a central activating effect, but in recent years it has been revealed that it has a platelet aggregation inhibitory effect, and it has come to be said to be effective in preventing arteriosclerosis. (Kozo Nakanishi et al., 1982, Clinical and Research 59,
3671-3674). Furthermore, it has recently been revealed that ginsenoside-Rg 1 has the effect of improving blood lipid levels in hyperlipidemic animals (Masahiro Yamamoto et al., Journal of the Japanese and Chinese Pharmaceutical Society 2, 377-385). In addition, ginsenoside-Rg 1 has come to be used as a standard reagent for thin-layer chromatography in confirmation tests for "Red ginseng" and "Ninjin" in the 11th edition of the Japanese Pharmacopoeia. Thus, ginsenosides
Rg 1 has become an important compound, and it has therefore become necessary to devise a suitable method for purifying it.

(従来の技術) ところが、今までは、カラムクロマトグラフイ
ー(以下、これをカラムクロマトという)によつ
て生薬の抽出物から分離できることが知られてい
るだけであつた。すなわち、上記のような多種類
のサポニン含有物をカラムクロマトによつて分画
してジンセノサイド―Rg1(以下、これをRg1とい
う)を得て来たが、実際には、それだけではまだ
純粋でないので、これを純粋にするために、これ
を一旦アセチル誘導体に変化させてこれを分離
し、その後アセチル誘導体からアセチル基を除去
してRg1に戻す、という複雑な方法が採用され
た。(Y.NAGAI他、Tetrahedron Vol.27,
pp881〔1971〕)。また、そこでは、こうして得ら
れたRg1をさらにn―ブタノール―メチルエチル
ケトン中で再結晶により精製していた。しかし、
このような精製方法は甚だ複雑で工業的に実施容
易ではない。
(Prior Art) However, until now, it was only known that crude drugs can be separated from extracts by column chromatography (hereinafter referred to as column chromatography). In other words, ginsenoside-Rg 1 (hereinafter referred to as Rg 1 ) has been obtained by fractionating the various types of saponin-containing substances mentioned above using column chromatography, but in reality, it is still not pure. Therefore, in order to purify it, a complicated method was adopted in which it was first converted into an acetyl derivative, separated, and then the acetyl group was removed from the acetyl derivative to return it to Rg 1 . (Y.NAGAI et al., Tetrahedron Vol.27,
pp881 [1971]). There, the thus obtained Rg 1 was further purified by recrystallization in n-butanol-methyl ethyl ketone. but,
Such a purification method is extremely complicated and is not easy to implement industrially.

因みに、上記の文献ではこうして精製された化
合物が、セミクリスタルであつたと記載され、融
点194〜196.5℃で、〔α〕19 D=+32゜(ピリジン)の
性質を持つと報告されていた。
Incidentally, the above-mentioned literature describes that the compound thus purified was semicrystalline, with a melting point of 194 to 196.5°C and a property of [α] 19 D = +32° (pyridine).

(発明が解決しようとする問題点) この発明は、上述のようなサポニンの混合物の
中から、Rg1だけを簡単に分離する方法を提供す
ることにある。
(Problems to be Solved by the Invention) The object of the present invention is to provide a method for easily separating only Rg 1 from a mixture of saponins as described above.

(問題を解決するための手段) この発明者は、カラムクロマトによつてRg1
分画しただけでは、純度のよいRg1を得るのが困
難であることを知つた。ところが、カラムクロマ
トによつて得た分画物を冷水、例えば4℃の水に
溶解して飽和溶液を作り、この飽和溶液を分離し
てこれをより高い温度、例えば28℃の温度にする
と、Rg1が水溶液中に析出してくることを見出し
た。しかも、その析出物が美麗な結晶となること
を見出した。さらに、この発明者は、Rg1が、通
常の有機化合物、とくにそこに混在する他の化合
物と異なり、常温付近においては高温ほど、溶解
度を減少させる特性を持つこと、及びそのために
上述のような結果が得られることを見出した。こ
の発明は、このような知見に基づいてなされたも
のである。
(Means for Solving the Problem) The inventor found that it is difficult to obtain Rg 1 with good purity just by fractionating Rg 1 by column chromatography. However, if the fraction obtained by column chromatography is dissolved in cold water, e.g., water at 4°C to create a saturated solution, and this saturated solution is separated and brought to a higher temperature, e.g., 28°C, It was discovered that Rg 1 precipitates in an aqueous solution. Furthermore, they discovered that the precipitate forms beautiful crystals. Furthermore, the inventor discovered that, unlike ordinary organic compounds, especially other compounds mixed therein, Rg 1 has the property that its solubility decreases as the temperature rises around room temperature, and for this reason, the above-mentioned We have found that results can be obtained. This invention was made based on such knowledge.

(発明の要旨) この発明は、Rg1が含まれている材料を水に溶
解して、0℃〜20℃の範囲内の特定温度における
飽和溶液を作つてこれを分離し、この飽和溶液を
20℃〜30℃の温度に維持して、水溶液中に析出す
る結晶性固体を取出すことを特徴とする、Rg1
精製法に関するものである。
(Summary of the Invention) This invention dissolves a material containing Rg 1 in water to create a saturated solution at a specific temperature within the range of 0°C to 20°C, and separates this saturated solution.
The present invention relates to a method for purifying Rg 1 , which is characterized by maintaining the temperature at 20°C to 30°C and removing a crystalline solid precipitated in an aqueous solution.

この発明では、Rg1が含まれている材料とし
て、カラムクロマトによつて分画したものを用い
る。カラムクロマトは筒内に固体を充填して固定
相とし、その一端に試料の混合物を置き、適当な
展開剤で混合物を固定相中に移動させ、各成分の
吸着性や分配係数の相違に基づく移動速度の差を
利用して、混合物を分離する方法である。固定相
を構成する固体としては色々なものを用いること
ができ、例えばシリカゲル、活性アルミナ等を用
いることができ、展開剤としては種々の溶媒やガ
スを用いることができる。カラムクロマトは、こ
のように混合物の分離方法の一つであるから、
Rg1は当然カラムクロマトによつて分離できるは
ずである。しかし、実際にカラムクロマトによつ
て純度の高いRg1を得るには、煩瑣な操作が必要
とされ、従つて多くの時間と資材とが必要とされ
る。しかも、カラムクロマトによつて得られた材
料は、ジンセノサイドRg3,Rg2,Rf等を伴ない
やすく、これらをカラムクロマトによつて除去し
ようとすれば、収率の低下が極めて大きくなる。
In this invention, as a material containing Rg 1 , a material fractionated by column chromatography is used. In column chromatography, a solid is packed into a cylinder to serve as a stationary phase, a sample mixture is placed at one end of the column, and the mixture is moved into the stationary phase using an appropriate developing agent. This method uses differences in movement speed to separate mixtures. Various solids can be used as the solid that constitutes the stationary phase, such as silica gel, activated alumina, etc., and various solvents and gases can be used as the developing agent. Column chromatography is one of the methods for separating mixtures, so
Naturally, Rg 1 should be able to be separated by column chromatography. However, actually obtaining highly pure Rg 1 by column chromatography requires complicated operations and therefore requires a lot of time and materials. Moreover, the material obtained by column chromatography is likely to be accompanied by ginsenosides Rg 3 , Rg 2 , Rf, etc., and if these are attempted to be removed by column chromatography, the yield will be extremely reduced.

この発明では、Rg1が含まれている材料を水に
溶解して、まず飽和溶液を作る。水としては、イ
オン交換樹脂によつてイオンを除いた水、又は蒸
溜水を用いることが好ましい。飽和溶液を作る温
度はなるべく低温であることが望ましく、具体的
には0℃ないし20℃の範囲内の特定温度とするこ
とができる。飽和溶液を得るためには、当然のこ
とながら、Rg1が含まれている多量の材料を水に
入れ、数捨分間よく撹拌して溶解させ、不溶解分
を除くことによつて、飽和溶液とすることが望ま
しい。
In this invention, a saturated solution is first created by dissolving a material containing Rg 1 in water. As water, it is preferable to use water from which ions have been removed using an ion exchange resin or distilled water. The temperature at which the saturated solution is prepared is desirably as low as possible, and specifically can be a specific temperature within the range of 0°C to 20°C. Naturally, in order to obtain a saturated solution, a large amount of material containing Rg 1 is poured into water, stirred well for several minutes to dissolve it, and the insoluble matter is removed to form a saturated solution. It is desirable to do so.

この発明では、上記の飽和溶液を20゜〜30℃の
温度に維持して、Rg1を析出させる。例えば、4
℃で飽和溶液を得たときは、これを28℃に一夜放
置して溶液中に固体を析出させる。このように、
低温で得た飽和溶液を高温に維持して、溶液中に
固体が析出することは、極めて珍らしいことであ
る。これは前述のように、Rg1が通常の化合物と
異なつて、常温付近において高温ほど水に対する
溶解度を減少させる。という特性に基づいて起る
ことである。
In this invention, Rg 1 is precipitated by maintaining the above saturated solution at a temperature of 20° to 30°C. For example, 4
When a saturated solution is obtained at 28°C, it is left at 28°C overnight to precipitate a solid in the solution. in this way,
It is extremely rare for a saturated solution obtained at a low temperature to be maintained at a high temperature, resulting in the precipitation of solids in the solution. This is because, as mentioned above, unlike ordinary compounds, Rg 1 decreases its solubility in water as the temperature increases around room temperature. This happens based on the characteristics of

この発明では、上述のようにして水溶液中に固
体を析出させたのち、この固体を取出す。このた
めには、水溶液を傾瀉し、又は過する。こうし
て取出された固体は、美麗な結晶であつて、しか
も純度の高いRg1である。
In this invention, after a solid is precipitated in an aqueous solution as described above, this solid is taken out. For this purpose, the aqueous solution is decanted or filtered. The solid thus extracted is a beautiful crystal and is Rg 1 with high purity.

(発明の効果) この発明方法によれば、Rg1が含まれている材
料を水に溶解して、0゜〜20℃の範囲内の特定温度
における飽和溶液を作つてこれを分離し、この飽
和溶液を20〜30℃の温度に維持して、水溶液中に
析出する結晶性固体を取出すだけで、Rg1を結晶
として分離することができる。しかも、0゜〜20℃
の範囲内の特定温度も、また、20〜30℃の温度
も、何れも極めてありふれた温度であるので、こ
の温度に維持することが容易である。その上に、
こうして得られた結晶は美麗である。さらに、こ
うして得られた結晶の量が多い。例えば、4℃に
おいては、10gのRg1を水100Ωに溶解させるこ
とができる。これは28℃にすると、これから7g
ものRg1の結晶を析出させることができるので、
70%もの収率でRg1を析出させることができるこ
ととなり、従つて収率がよい。この発明は、この
ように顕著な効果をもたらすものである。
(Effect of the invention) According to the method of this invention, a material containing Rg 1 is dissolved in water to create a saturated solution at a specific temperature within the range of 0° to 20°C, and this is separated. Rg 1 can be isolated as crystals by simply maintaining the saturated solution at a temperature of 20-30°C and removing the crystalline solid that precipitates in the aqueous solution. Moreover, 0° to 20°C
Both the specific temperature within the range of 20 and 30° C. are extremely common temperatures, so it is easy to maintain them at these temperatures. in addition,
The crystals thus obtained are beautiful. Furthermore, the amount of crystals thus obtained is large. For example, at 4°C, 10g of Rg 1 can be dissolved in 100Ω of water. If this is heated to 28℃, this will be 7g.
Since crystals of Rg 1 can be precipitated,
This means that Rg 1 can be precipitated with a yield of 70%, which means that the yield is good. This invention brings such remarkable effects.

以下に実施例を挙げて、この発明方法の詳細を
説明する。
The details of the method of this invention will be explained below with reference to Examples.

実施例 カラムクロマトの分画により得られ溶媒を除去
したジンセノサイド―Rg1含有の粉末10gを、脱
イオン水100mlに4℃で撹拌しながら溶解し、残
渣を過した。こうして得られた溶液を28℃に一
夜放置したところ、溶液中に結晶が析出してい
た。この結晶を過して取出し、乾燥して7gの
結晶を得た。
Example 10 g of powder containing ginsenoside-Rg 1 obtained by column chromatography fractionation and from which the solvent was removed was dissolved in 100 ml of deionized water at 4° C. with stirring, and the residue was filtered. When the solution thus obtained was left at 28°C overnight, crystals were precipitated in the solution. The crystals were collected by filtration and dried to obtain 7 g of crystals.

この結晶は、融点208―211℃、〔α〕22 D:+33.9゜
であつた。この結晶は、薄層クロマトグラフイー
(クロロホルム:メタノール:水=65:35:10)
(下層)により、夾雑物を含まないことが確認さ
れた。
This crystal had a melting point of 208-211°C and [α] 22 D : +33.9°. This crystal can be obtained by thin layer chromatography (chloroform:methanol:water = 65:35:10).
(lower layer) confirmed that it did not contain any impurities.

Claims (1)

【特許請求の範囲】[Claims] 1 ジンセノサイド―Rg1が含まれている材料を
水に溶解して、0゜〜20℃の範囲内の特定温度にお
ける飽和溶液を作り、その飽和溶液を20゜〜30℃
の温度に維持して、水溶液中に析出する結晶性固
体を分離することを特徴とする、ジンセノサイド
―Rg1の精製法。
1 Dissolve the material containing ginsenoside-Rg 1 in water to create a saturated solution at a specific temperature within the range of 0° to 20°C, and then heat the saturated solution to 20° to 30°C.
1. A method for purifying ginsenoside-Rg 1 , which comprises maintaining the temperature at a temperature of 100 mL to separate a crystalline solid precipitated in an aqueous solution.
JP17647786A 1986-07-26 1986-07-26 Purification of ginsenoside-rg1 Granted JPS6333393A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17647786A JPS6333393A (en) 1986-07-26 1986-07-26 Purification of ginsenoside-rg1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17647786A JPS6333393A (en) 1986-07-26 1986-07-26 Purification of ginsenoside-rg1

Publications (2)

Publication Number Publication Date
JPS6333393A JPS6333393A (en) 1988-02-13
JPH0212960B2 true JPH0212960B2 (en) 1990-03-30

Family

ID=16014354

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17647786A Granted JPS6333393A (en) 1986-07-26 1986-07-26 Purification of ginsenoside-rg1

Country Status (1)

Country Link
JP (1) JPS6333393A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0575638U (en) * 1992-03-16 1993-10-15 山武ハネウエル株式会社 Field instrument

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532234A (en) * 2010-12-10 2012-07-04 北京本草天源药物研究院 Method for extracting and purifying ginsenoside Rg1

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0575638U (en) * 1992-03-16 1993-10-15 山武ハネウエル株式会社 Field instrument

Also Published As

Publication number Publication date
JPS6333393A (en) 1988-02-13

Similar Documents

Publication Publication Date Title
JPH0399090A (en) Method for preparation of extract containing highly pure anthocyanosides from plant or its extract
KR940002795B1 (en) Separation and purification in ginkgo
US5430054A (en) Preparation methods of diterpene lactone compounds and application of the same to antifertility
JPS6232173B2 (en)
US6218541B1 (en) Method for extracting bisbenzylisoquinolines
CN109096232B (en) A bibenzyl dimer compound and its extraction and separation method and application from Dendrobium nobile
CN1546451A (en) Hydroxy anthraquinone derivatives and application thereof in preparation of anti-cancer drugs
JPH0212960B2 (en)
JPS6039647B2 (en) Method for isolating gamma-L-glutamyl-taurine
CN1052859A (en) Structure and preparation method of 17-hydroxytriptolide and its analogs
JP3544223B2 (en) New hair growth and hair growth promoter
CN101362746B (en) Separation method and polymorphic form of single stereoisomer of argatroban
US3839317A (en) Digoxin complexes
CS223879B2 (en) Method of gaining natural terpenes with antipsoriatic effect
JPH0678231B2 (en) Blood viscosity reducing agent
US5233034A (en) Process for the purification of hemin, a novel derivative and process for its preparation
KR920007273B1 (en) Sugar derivatives of protocategoaldehydes
JP2792010B2 (en) Phthalide derivative and cell killer for cervical cancer cells containing the same as active ingredient
JPH01246299A (en) Ergosterol derivative and production thereof
KR940002796B1 (en) Method of isolation and purification of ginkgolide of ginkgo
JP2757342B2 (en) Isoindolinone derivative, cervical cancer cell killing agent containing the same as active ingredient, and method for producing the same
EP2848251B1 (en) Extracts and isolated compounds from Cakile arabica for treatment of ulcer
US4144254A (en) Process for the purification of steroids
CN117720551B (en) Sesquiterpenoids and preparation method and application thereof
Machulla et al. Iodination methods for routine preparation of 17-123I-heptadecanoic acid and 15-(123I-phenyl)-pentadecanoic acid